{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T01:17:23Z","timestamp":1792718243790,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2009,6,26]],"date-time":"2009-06-26T00:00:00Z","timestamp":1245974400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Anaesthesist"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1007\/s00101-009-1575-3","type":"journal-article","created":{"date-parts":[[2009,6,24]],"date-time":"2009-06-24T21:14:28Z","timestamp":1245878068000},"page":"708-715","source":"Crossref","is-referenced-by-count":12,"title":["\u201eTarget-controlled infusion\u201c","Target-controlled infusion"],"prefix":"10.1007","volume":"58","author":[{"given":"H.","family":"Ihmsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Schraag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Kreuer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Bruhn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Albrecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,6,26]]},"reference":[{"key":"1575_CR1","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/bja\/aeg220","volume":"91","author":"Absalom","year":"2003","unstructured":"Absalom A, Amutike D, Lal A et al (2003) Accuracy of the \u201aPaedfusor\u2018 in children undergoing cardiac surgery or catheterization. Br J Anaesth 91:507\u2013513","journal-title":"Br J Anaesth"},{"key":"1575_CR2","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1093\/bja\/ael321","volume":"98","author":"Albertin","year":"2007","unstructured":"Albertin A, Poli D, La Colla L et al (2007) Predictive performance of \u201eServin\u2019s formula\u201c during BIS-guided propofol-remifentanil target-controlled infusion in morbidly obese patients. Br J Anaesth 98:66\u201375","journal-title":"Br J Anaesth"},{"key":"1575_CR3","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1097\/00000542-200311000-00013","volume":"99","author":"Avram","year":"2003","unstructured":"Avram MJ, Krejcie TC (2003) Using front-end kinetics to optimize target-controlled drug infusions. Anesthesiology 99:1078\u20131086","journal-title":"Anesthesiology"},{"key":"1575_CR4","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/j.1365-2044.2007.05059.x","volume":"62","author":"Barakat","year":"2007","unstructured":"Barakat AR, Sutcliffe N, Schwab M (2007) Effect site concentration during propofol TCI sedation: a comparison of sedation score with two pharmacokinetic models. Anaesthesia 62:661\u2013666","journal-title":"Anaesthesia"},{"key":"1575_CR5","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2165\/00003088-198917030-00004","volume":"17","author":"Chiou","year":"1989","unstructured":"Chiou WL (1989) The phenomenon and rationale of marked dependence of drug concentration on blood sampling site. Implications in pharmacokinetics, pharmacodynamics, toxicology and therapeutics (part\u00a0I). Clin Pharmacokinet 17:175\u2013199","journal-title":"Clin Pharmacokinet"},{"key":"1575_CR6","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1002\/jps.2600690738","volume":"69","author":"Chiou","year":"1980","unstructured":"Chiou WL (1980) Potential effect of early blood sampling schedule on calculated pharmacokinetic parameters of drugs after intravenous administration. J Pharm Sci 69:867\u2013869","journal-title":"J Pharm Sci"},{"key":"1575_CR7","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/BF01062393","volume":"7","author":"Chiou","year":"1979","unstructured":"Chiou WL (1979) Potential pitfalls in the conventional pharmacokinetic studies: effects of the initial mixing of drug in blood and the pulmonary first-pass elimination. J Pharmacokinet Biopharm 7:527\u2013536","journal-title":"J Pharmacokinet Biopharm"},{"key":"1575_CR8","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1097\/00000542-200311000-00003","volume":"99","author":"Egan","year":"2003","unstructured":"Egan TD, Shafer SL (2003) Target-controlled infusions for intravenous anesthetics: surfing USA not! Anesthesiology 99:1039\u20131041","journal-title":"Anesthesiology"},{"key":"1575_CR9","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3109\/2000-1967-222","volume":"113","author":"Enlund","year":"2008","unstructured":"Enlund M (2008) TCI: Target controlled infusion, or totally confused infusion? Call for an optimised population based pharmacokinetic model for propofol. Ups J Med Sci 113:161\u2013170","journal-title":"Ups J Med Sci"},{"key":"1575_CR10","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1213\/00000539-198712000-00010","volume":"66","author":"Gepts","year":"1987","unstructured":"Gepts E, Camu F, Cockshott ID, Douglas EJ (1987) Disposition of propofol administered as constant rate intravenous infusions in humans. Anesth Analg 66:1256\u20131263","journal-title":"Anesth Analg"},{"key":"1575_CR11","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1097\/00000542-199512000-00010","volume":"83","author":"Gepts","year":"1995","unstructured":"Gepts E, Shafer SL, Camu F et al (1995) Linearity of pharmacokinetics and model estimation of sufentanil. Anesthesiology 83:1194\u20131204","journal-title":"Anesthesiology"},{"key":"1575_CR12","doi-asserted-by":"crossref","unstructured":"Gibaldi M, Perrier D (1982) Pharmacokinetics, 2nd edn. Dekker, New York Basel","DOI":"10.1201\/b14095"},{"key":"1575_CR13","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1093\/bja\/aep043","volume":"102","author":"Glen","year":"2009","unstructured":"Glen JB, Servin F (2009) Evaluation of the predictive performance of four pharmacokinetic models for propofol. Br J Anaesth 102:626\u2013632","journal-title":"Br J Anaesth"},{"key":"1575_CR14","first-page":"H903","volume":"262","author":"Henthorn","year":"1992","unstructured":"Henthorn TK, Avram MJ, Krejcie TC et al (1992) Minimal compartmental model of circulatory mixing of indocyanine green. Am J Physiol 262:H903\u2013H910","journal-title":"Am J Physiol"},{"key":"1575_CR15","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0163-7258(82)90051-1","volume":"16","author":"Holford","year":"1982","unstructured":"Holford NH, Sheiner LB (1982) Kinetics of pharmacologic response. Pharmacol Ther 16:143\u2013166","journal-title":"Pharmacol Ther"},{"key":"1575_CR16","unstructured":"James WPT (1976) Research on obesity. Her Majesty\u2019s Stationary Office, London"},{"key":"1575_CR17","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.2165\/00003088-200544100-00004","volume":"44","author":"Janmahasatian","year":"2005","unstructured":"Janmahasatian S, Duffull SB, Ash S et al (2005) Quantification of lean bodyweight. Clin Pharmacokinet 44:1051\u20131065","journal-title":"Clin Pharmacokinet"},{"key":"1575_CR18","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/00000542-199401000-00018","volume":"80","author":"Kataria","year":"1994","unstructured":"Kataria BK, Ved SA, Nicodemus HF et al (1994) The pharmacokinetics of propofol in children using three different data analysis approaches. Anesthesiology 80:104\u2013122","journal-title":"Anesthesiology"},{"key":"1575_CR19","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/S0022-3565(25)20752-2","volume":"278","author":"Krejcie","year":"1996","unstructured":"Krejcie TC, Henthorn TK, Niemann CU et al (1996) Recirculatory pharmacokinetic models of markers of blood, extracellular fluid and total body water administered concomitantly. J Pharmacol Exp Ther 278:1050\u20131057","journal-title":"J Pharmacol Exp Ther"},{"key":"1575_CR20","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1381\/0960892054621350","volume":"15","author":"Lemmens","year":"2005","unstructured":"Lemmens HJ, Brodsky JB, Bernstein DP (2005) Estimating ideal body weight \u2013 A new formula. Obes Surg 15:1082\u20131083","journal-title":"Obes Surg"},{"key":"1575_CR21","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00000542-198701000-00002","volume":"66","author":"Maitre","year":"1987","unstructured":"Maitre PO, Vozeh S, Heykants J et al (1987) Population pharmacokinetics of alfentanil: the average dose-plasma concentration relationship and interindividual variability in patients. Anesthesiology 66:3\u201312","journal-title":"Anesthesiology"},{"key":"1575_CR22","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/bja\/67.1.41","volume":"67","author":"Marsh","year":"1991","unstructured":"Marsh B, White M, Morton N, Kenny GN (1991) Pharmacokinetic model driven infusion of propofol in children. Br J Anaesth 67:41\u201348","journal-title":"Br J Anaesth"},{"key":"1575_CR23","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/00000542-199701000-00004","volume":"86","author":"Minto","year":"1997","unstructured":"Minto CF, Schnider TW, Egan TD et al (1997) Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I. Model development. Anesthesiology 86:10\u201323","journal-title":"Anesthesiology"},{"key":"1575_CR24","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/00000542-200308000-00014","volume":"99","author":"Minto","year":"2003","unstructured":"Minto CF, Schnider TW, Gregg KM et al (2003) Using the time of maximum effect site concentration to combine pharmacokinetics and pharmacodynamics. Anesthesiology 99:324\u2013333","journal-title":"Anesthesiology"},{"key":"1575_CR25","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1213\/ane.0b013e318198f6dc","volume":"108","author":"Moerman","year":"2009","unstructured":"Moerman AT, Herregods LL, de Vos MM et al (2009) Manual versus target-controlled infusion remifentanil administration in spontaneously breathing patients. Anesth Analg 108:828\u2013834","journal-title":"Anesth Analg"},{"key":"1575_CR26","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1097\/00000542-199805000-00006","volume":"88","author":"Schnider","year":"1998","unstructured":"Schnider TW, Minto CF, Gambus PL et al (1998) The influence of method of administration and covariates on the pharmacokinetics of propofol in adult volunteers. Anesthesiology 88:1170\u20131182","journal-title":"Anesthesiology"},{"key":"1575_CR27","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1097\/00000542-199906000-00003","volume":"90","author":"Schnider","year":"1999","unstructured":"Schnider TW, Minto CF, Shafer SL et al (1999) The influence of age on propofol pharmacodynamics. Anesthesiology 90:1502\u20131516","journal-title":"Anesthesiology"},{"key":"1575_CR28","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00101-008-1329-7","volume":"57","author":"Schraag","year":"2008","unstructured":"Schraag S, Kreuer S, Bruhn J et al (2008) Target-controlled infusion (TCI) \u2013 Ein Konzept mit Zukunft? Standortbestimmung, Handlungsempfehlungen und Blick in die Zukunft. Anaesthesist 57:223\u2013230","journal-title":"Anaesthesist"},{"key":"1575_CR29","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/00000542-200003000-00017","volume":"92","author":"Schuttler","year":"2000","unstructured":"Schuttler J, Ihmsen H (2000) Population pharmacokinetics of propofol: a multicenter study. Anesthesiology 92:727\u2013738","journal-title":"Anesthesiology"},{"key":"1575_CR30","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/BF00615409","volume":"20","author":"Schwilden","year":"1981","unstructured":"Schwilden H (1981) A general method for calculating the dosage scheme in linear pharmacokinetics. Eur J Clin Pharmacol 20:379\u2013386","journal-title":"Eur J Clin Pharmacol"},{"key":"1575_CR31","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1097\/00000542-199304000-00008","volume":"78","author":"Servin","year":"1993","unstructured":"Servin F, Farinotti R, Haberer JP, Desmonts JM (1993) Propofol infusion for maintenance of anesthesia in morbidly obese patients receiving nitrous oxide. A clinical and pharmacokinetic study. Anesthesiology 78:657\u2013665","journal-title":"Anesthesiology"},{"key":"1575_CR32","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/01.anes.0000278902.15505.f8","volume":"107","author":"Struys","year":"2007","unstructured":"Struys MM, Coppens MJ, De Neve N et al (2007) Influence of administration rate on propofol plasma-effect site equilibration. Anesthesiology 107:386\u2013396","journal-title":"Anesthesiology"},{"key":"1575_CR33","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/00000542-200002000-00021","volume":"92","author":"Struys","year":"2000","unstructured":"Struys MM, De Smet T, Depoorter B et al (2000) Comparison of plasma compartment versus two methods for effect compartment \u2013 controlled target-controlled infusion for propofol. Anesthesiology 92:399\u2013406","journal-title":"Anesthesiology"},{"key":"1575_CR34","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1023\/A:1025767710234","volume":"25","author":"Tuk","year":"1997","unstructured":"Tuk B, Danhof M, Mandema JW (1997) The impact of arteriovenous concentration differences on pharmacodynamic parameter estimates. J Pharmacokinet Biopharm 25:39\u201362","journal-title":"J Pharmacokinet Biopharm"},{"key":"1575_CR35","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2165\/00003088-200847020-00005","volume":"47","author":"White","year":"2008","unstructured":"White M, Kenny GN, Schraag S (2008) Use of target controlled infusion to derive age and gender covariates for propofol clearance. Clin Pharmacokinet 47:119\u2013127","journal-title":"Clin Pharmacokinet"}],"container-title":["Der Anaesthesist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00101-009-1575-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00101-009-1575-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00101-009-1575-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T09:31:47Z","timestamp":1739179907000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00101-009-1575-3"}},"subtitle":["Klinische Relevanz und Besonderheiten im Umgang mit pharmakokinetischen Modellen","Clinical relevance and special features when using pharmacokinetic models"],"short-title":[],"issued":{"date-parts":[[2009,6,26]]},"references-count":35,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["1575"],"URL":"https:\/\/doi.org\/10.1007\/s00101-009-1575-3","relation":{},"ISSN":["0003-2417","1432-055X"],"issn-type":[{"value":"0003-2417","type":"print"},{"value":"1432-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,6,26]]}}}